Pfizer funnels $15M into 3-year ACS initiative designed to tackle cancer care disparities

Pfizer is putting down $15 million to launch a new program with the American Cancer Society (ACS) aimed at improving access to cancer screening and clinical trials in medically underrepresented communities nationwide.